Quality of clinical evidence and political justifications of ivermectin mass distribution of COVID-19 kits in eight Latin American countries

BACKGROUND: Several countries in Latin America conducted mass distribution of COVID-19 kits intended to treat mild COVID-19, thereby preventing excess hospitalisations. Many of the kits contained ivermectin, an antiparasitic medicine that was not approved at the time for the treatment of COVID-19. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Requejo Domínguez, José Antonio, Mino-León, Dolores, Wirtz, Veronika J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230343/
https://www.ncbi.nlm.nih.gov/pubmed/37225261
http://dx.doi.org/10.1136/bmjgh-2022-010962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230343/
https://www.ncbi.nlm.nih.gov/pubmed/37225261
http://dx.doi.org/10.1136/bmjgh-2022-010962

Ejemplares similares